Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Ret Proto-Oncogene Antikörper

Der Maus Monoklonal Anti-Ret Proto-Oncogene-Antikörper wurde für WB, IHC (p) und IF validiert. Er ist geeignet, Ret Proto-Oncogene in Proben von Human und Maus zu detektieren.
Produktnummer ABIN4913582

Kurzübersicht für Ret Proto-Oncogene Antikörper (ABIN4913582)

Target

Alle Ret Proto-Oncogene (RET) Antikörper anzeigen
Ret Proto-Oncogene (RET)

Reaktivität

  • 173
  • 96
  • 73
  • 5
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Human, Maus

Wirt

  • 179
  • 43
  • 2
  • 2
  • 1
  • 1
Maus

Klonalität

  • 177
  • 51
Monoklonal

Konjugat

  • 95
  • 15
  • 11
  • 9
  • 6
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
Dieser Ret Proto-Oncogene Antikörper ist unkonjugiert

Applikation

  • 172
  • 86
  • 65
  • 65
  • 54
  • 26
  • 18
  • 17
  • 14
  • 12
  • 10
  • 5
  • 4
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunofluorescence (IF)

Klon

8C3
  • Kreuzreaktivität

    Human, Maus

    Aufreinigung

    Mouse monoclonal antibody supplied in crude ascites with 0.09% (W/V) sodium azide.

    Immunogen

    This RET Monoclonal antibody was raised using purified His-tagged recombinant human RET.

    Isotyp

    IgM
  • Applikationshinweise

    WB 1:300-5000
    IHC-P 1:200-400
    IF()

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Konzentration

    0.5 μg/μL

    Buffer

    0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.

    Konservierungsmittel

    ProClin

    Vorsichtsmaßnahmen

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    Store at -20°C for 12 months.

    Haltbarkeit

    12 months
  • Target

    Ret Proto-Oncogene (RET)

    Andere Bezeichnung

    RET

    Hintergrund

    Synonyms: PTC, MTC1, HSCR1, MEN2A, MEN2B, RET51, CDHF12, CDHR16, RET-ELE1, Proto-oncogene tyrosine-protein kinase receptor Ret, Cadherin family member 12, Proto-oncogene c-Ret, RET

    Background: Receptor tyrosine-protein kinase involved in numerous cellular mechanisms including cell proliferation, neuronal navigation, cell migration, and cell differentiation upon binding with glial cell derived neurotrophic factor family ligands. Phosphorylates PTK2/FAK1. Regulates both cell death/survival balance and positional information. Required for the molecular mechanisms orchestration during intestine organogenesis, involved in the development of enteric nervous system and renal organogenesis during embryonic life, and promotes the formation of Peyer's patch-like structures, a major component of the gut-associated lymphoid tissue. Modulates cell adhesion via its cleavage by caspase in sympathetic neurons and mediates cell migration in an integrin (e.g. ITGB1 and ITGB3)-dependent manner. Involved in the development of the neural crest. Active in the absence of ligand, triggering apoptosis through a mechanism that requires receptor intracellular caspase cleavage. Acts as a dependence receptor, in the presence of the ligand GDNF in somatotrophs (within pituitary), promotes survival and down regulates growth hormone (GH) production, but triggers apoptosis in absence of GDNF. Regulates nociceptor survival and size. Triggers the differentiation of rapidly adapting (RA) mechanoreceptors. Mediator of several diseases such as neuroendocrine cancers, these diseases are characterized by aberrant integrins-regulated cell migration.

    Gen-ID

    5979

    UniProt

    P07949

    Pathways

    RTK Signalweg, Dopaminergic Neurogenesis, Regulation of Cell Size, Tube Formation
Sie sind hier:
Chat with us!